$LOXO Announces Initiation of Phase 12 Clinical Trial for Highly Selective NonCovalent BTK Inhibitor LOXO305 httpsglobenewswire.comnewsrelease2018122116775740enLoxoOncologyAnnouncesInitiationofPhase12ClinicalTrialforHighlySele

$LOXO Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305 https://globenewswire.com/news-release/2018/12/21/1677574/0/en/Loxo-Oncology-Announces-Initiation-of-Phase-1-2-Clinical-Trial-for-Highly-Sele

06:46 EST 21 Dec 2018 | Odi Bruckman

$LOXO Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305 https://globenewswire.com/news-release/2018/12/21/1677574/0/en/Loxo-Oncology-Announces-Initiation-of-Phase-1-2-Clinical-Trial-for-Highly-Selective-Non-Covalent-BTK-Inhibitor-LOXO-305.html …

More From BioPortfolio on "$LOXO Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305 https://globenewswire.com/news-release/2018/12/21/1677574/0/en/Loxo-Oncology-Announces-Initiation-of-Phase-1-2-Clinical-Trial-for-Highly-Sele"